Recurrent venous thromboembolism occurred in @ patients in the warfarin group and @ patients in the placebo group ( HR , @ ; @ % CI , @-@ @ ) ; major bleeding occurred in @ patients in the warfarin group and in @ patient in the placebo group ( HR , @ ; @ % CI , @ to @ ) .